Marchés français ouverture 6 h 26 min
  • Dow Jones

    29 872,47
    -173,77 (-0,58 %)
     
  • Nasdaq

    12 094,40
    +57,62 (+0,48 %)
     
  • Nikkei 225

    26 371,45
    +74,59 (+0,28 %)
     
  • EUR/USD

    1,1930
    +0,0011 (+0,10 %)
     
  • HANG SENG

    26 669,75
    0,00 (0,00 %)
     
  • BTC-EUR

    15 744,66
    -67,91 (-0,43 %)
     
  • CMC Crypto 200

    369,21
    -1,31 (-0,35 %)
     
  • S&P 500

    3 629,65
    -5,76 (-0,16 %)
     

Global Vial Adaptors for Reconstitution Drug Industry

ReportLinker
·24 min de lecture

Global Vial Adaptors for Reconstitution Drug Market to Reach $1. 5 Billion by 2027. Amid the COVID-19 crisis, the global market for Vial Adaptors for Reconstitution Drug estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.

New York, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vial Adaptors for Reconstitution Drug Industry" - https://www.reportlinker.com/p05961216/?utm_source=GNW
5 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Polycarbonate, one of the segments analyzed in the report, is projected to record a 6.8% CAGR and reach US$913.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Silicon segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $296.1 Million, While China is Forecast to Grow at 5.7% CAGR

The Vial Adaptors for Reconstitution Drug market in the U.S. is estimated at US$296.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$266.5 Million by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Polyethylene Teraphthalate Glycol Segment to Record 5.3% CAGR

In the global Polyethylene Teraphthalate Glycol segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$68.6 Million in the year 2020 will reach a projected size of US$98.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$174.5 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 193-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Baxter International, Inc.

  • Becton, Dickinson and Company

  • Cardinal Health, Inc.

  • Sensile Medical AG

  • Unilife Corporation

  • West Pharmaceutical Services, Inc.




Read the full report: https://www.reportlinker.com/p05961216/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Vial Adaptors for Reconstitution Drug Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 2: World Historic Review for Vial Adaptors for
Reconstitution Drug by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019

Table 3: World 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2012, 2020 &
2027

Table 4: World Current & Future Analysis for Polycarbonate by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 5: World Historic Review for Polycarbonate by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 6: World 15-Year Perspective for Polycarbonate by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Silicon by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 8: World Historic Review for Silicon by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 9: World 15-Year Perspective for Silicon by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Polyethylene
Teraphthalate Glycol by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 11: World Historic Review for Polyethylene Teraphthalate
Glycol by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019

Table 12: World 15-Year Perspective for Polyethylene
Teraphthalate Glycol by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Polyethylene by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 14: World Historic Review for Polyethylene by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019

Table 15: World 15-Year Perspective for Polyethylene by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Other Materials
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 17: World Historic Review for Other Materials by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 18: World 15-Year Perspective for Other Materials by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Autoimmune
Diseases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027

Table 20: World Historic Review for Autoimmune Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 21: World 15-Year Perspective for Autoimmune Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Infectious
Diseases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027

Table 23: World Historic Review for Infectious Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 24: World 15-Year Perspective for Infectious Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Metabolic
Conditions by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027

Table 26: World Historic Review for Metabolic Conditions by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 27: World 15-Year Perspective for Metabolic Conditions by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Reproductive
Health by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027

Table 29: World Historic Review for Reproductive Health by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 30: World 15-Year Perspective for Reproductive Health by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Other Therapeutic
Areas by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 32: World Historic Review for Other Therapeutic Areas by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 33: World 15-Year Perspective for Other Therapeutic Areas
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Vial Adaptors for Reconstitution Drug Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 34: USA Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 35: USA Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 36: USA 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 37: USA Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 38: USA Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 39: USA 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

CANADA
Table 40: Canada Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 41: Canada Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 42: Canada 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 43: Canada Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Therapeutic Area - Autoimmune
Diseases, Infectious Diseases, Metabolic Conditions,
Reproductive Health and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 44: Canada Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 45: Canada 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 47: Japan Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 48: Japan 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 49: Japan Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 50: Japan Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 51: Japan 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

CHINA
Table 52: China Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 53: China Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 54: China 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 55: China Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 56: China Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 57: China 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Vial Adaptors for Reconstitution Drug Market:
Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 58: Europe Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027

Table 59: Europe Historic Review for Vial Adaptors for
Reconstitution Drug by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 60: Europe 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 61: Europe Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 62: Europe Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 63: Europe 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 64: Europe Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Therapeutic Area - Autoimmune
Diseases, Infectious Diseases, Metabolic Conditions,
Reproductive Health and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 65: Europe Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 66: Europe 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

FRANCE
Table 67: France Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 68: France Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 69: France 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 70: France Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Therapeutic Area - Autoimmune
Diseases, Infectious Diseases, Metabolic Conditions,
Reproductive Health and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 71: France Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 72: France 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

GERMANY
Table 73: Germany Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 74: Germany Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 75: Germany 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 76: Germany Current & Future Analysis for Vial Adaptors
for Reconstitution Drug by Therapeutic Area - Autoimmune
Diseases, Infectious Diseases, Metabolic Conditions,
Reproductive Health and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 77: Germany Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 78: Germany 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

ITALY
Table 79: Italy Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 80: Italy Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 81: Italy 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 82: Italy Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 83: Italy Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 84: Italy 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 85: UK Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 86: UK Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 87: UK 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Material - Percentage Breakdown of Value
Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate
Glycol, Polyethylene and Other Materials for the Years 2012,
2020 & 2027

Table 88: UK Current & Future Analysis for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 89: UK Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 90: UK 15-Year Perspective for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Percentage Breakdown
of Value Sales for Autoimmune Diseases, Infectious Diseases,
Metabolic Conditions, Reproductive Health and Other Therapeutic
Areas for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for Vial
Adaptors for Reconstitution Drug by Material - Polycarbonate,
Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and
Other Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 92: Rest of Europe Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 93: Rest of Europe 15-Year Perspective for Vial Adaptors
for Reconstitution Drug by Material - Percentage Breakdown of
Value Sales for Polycarbonate, Silicon, Polyethylene
Teraphthalate Glycol, Polyethylene and Other Materials for the
Years 2012, 2020 & 2027

Table 94: Rest of Europe Current & Future Analysis for Vial
Adaptors for Reconstitution Drug by Therapeutic Area -
Autoimmune Diseases, Infectious Diseases, Metabolic Conditions,
Reproductive Health and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 95: Rest of Europe Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 96: Rest of Europe 15-Year Perspective for Vial Adaptors
for Reconstitution Drug by Therapeutic Area - Percentage
Breakdown of Value Sales for Autoimmune Diseases, Infectious
Diseases, Metabolic Conditions, Reproductive Health and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 97: Asia-Pacific Current & Future Analysis for Vial
Adaptors for Reconstitution Drug by Material - Polycarbonate,
Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and
Other Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 98: Asia-Pacific Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 99: Asia-Pacific 15-Year Perspective for Vial Adaptors
for Reconstitution Drug by Material - Percentage Breakdown of
Value Sales for Polycarbonate, Silicon, Polyethylene
Teraphthalate Glycol, Polyethylene and Other Materials for the
Years 2012, 2020 & 2027

Table 100: Asia-Pacific Current & Future Analysis for Vial
Adaptors for Reconstitution Drug by Therapeutic Area -
Autoimmune Diseases, Infectious Diseases, Metabolic Conditions,
Reproductive Health and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 101: Asia-Pacific Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 102: Asia-Pacific 15-Year Perspective for Vial Adaptors
for Reconstitution Drug by Therapeutic Area - Percentage
Breakdown of Value Sales for Autoimmune Diseases, Infectious
Diseases, Metabolic Conditions, Reproductive Health and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

REST OF WORLD
Table 103: Rest of World Current & Future Analysis for Vial
Adaptors for Reconstitution Drug by Material - Polycarbonate,
Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and
Other Materials - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027

Table 104: Rest of World Historic Review for Vial Adaptors for
Reconstitution Drug by Material - Polycarbonate, Silicon,
Polyethylene Teraphthalate Glycol, Polyethylene and Other
Materials Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019

Table 105: Rest of World 15-Year Perspective for Vial Adaptors
for Reconstitution Drug by Material - Percentage Breakdown of
Value Sales for Polycarbonate, Silicon, Polyethylene
Teraphthalate Glycol, Polyethylene and Other Materials for the
Years 2012, 2020 & 2027

Table 106: Rest of World Current & Future Analysis for Vial
Adaptors for Reconstitution Drug by Therapeutic Area -
Autoimmune Diseases, Infectious Diseases, Metabolic Conditions,
Reproductive Health and Other Therapeutic Areas - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 107: Rest of World Historic Review for Vial Adaptors for
Reconstitution Drug by Therapeutic Area - Autoimmune Diseases,
Infectious Diseases, Metabolic Conditions, Reproductive Health
and Other Therapeutic Areas Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019

Table 108: Rest of World 15-Year Perspective for Vial Adaptors
for Reconstitution Drug by Therapeutic Area - Percentage
Breakdown of Value Sales for Autoimmune Diseases, Infectious
Diseases, Metabolic Conditions, Reproductive Health and Other
Therapeutic Areas for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 46
Read the full report: https://www.reportlinker.com/p05961216/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001